^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    EGFR806-specific CAR T-cell therapy

    i
    Company:
    Cellevolve Bio, Seattle Children's Hospital, Seattle Children’s Therapeutics
    Drug class:
    EGFR-targeted CAR-T immunotherapy
    Related drugs: